Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Workman

Showing results (41-50 of 268) with videos related to

Pageof 27
Sort By:
Anti-Cancer Drug Design|December 1, 1994
Signalling targets for the development of cancer drugsG Powis, P Workman
Journal of Chromatography|September 4, 1987
Gradient high-performance liquid chromatographic method for simultaneous assay of the radiosensitizers etanidazole (SR 2508) and pimonidazole (Ro 03-8799) in biological materialsR Ward, P Workman
British Journal of Cancer|August 1, 1995
Growth arrest vs direct cytotoxicity and the importance of molecular structure for the in vitro anti-tumour activity of ether lipidsM Lohmeyer, P Workman
Anti-Cancer Drug Design|August 1, 1994
Signalling targets for the development of cancer drugsG Powis, P Workman
International Journal of Radiation Oncology, Biology, Physics|August 1, 1986
Interaction of nitroimidazole sensitizers with drug metabolizing enzymes--spectral and kinetic studiesF Y Lee, P Workman
Expert Opinion on Pharmacotherapy|October 5, 2001
Innovative cancer drug targets: genomics, transcriptomics and clinomicsP Workman, P A Clarke
International Journal of Cancer|January 2, 1994
Unusually marked hypoxic sensitization to indoloquinone EO9 and mitomycin C in a human colon-tumour cell line that lacks DT-diaphorase activityJ A Plumb, P Workman
Biochemical Pharmacology|January 15, 1978
Enzyme activated anti-tumor agents--IV. Comparative kinetics of N,N-p-di-2-chloroethylaminophenyl phosphate hydrolysis catalysed by phosphatases of normal and neoplastic tissuesP Workman, J A Double
Cancer Chemotherapy and Pharmacology|January 1, 1994
Is body composition an important variable in the pharmacokinetics of anticancer drugs? A review and suggestions for further researchJ J Reilly, P Workman
British Journal of Cancer|May 1, 1993
In vitro antitumour activity of the novel imidazoisoquinoline SDZ 62-434V G Brunton, P Workman
Pageof 27

Showing results (41-50 of 268) with videos related to

Sort By:
Pageof 27
Anti-Cancer Drug Design|December 1, 1994
Signalling targets for the development of cancer drugsG Powis, P Workman
Journal of Chromatography|September 4, 1987
Gradient high-performance liquid chromatographic method for simultaneous assay of the radiosensitizers etanidazole (SR 2508) and pimonidazole (Ro 03-8799) in biological materialsR Ward, P Workman
British Journal of Cancer|August 1, 1995
Growth arrest vs direct cytotoxicity and the importance of molecular structure for the in vitro anti-tumour activity of ether lipidsM Lohmeyer, P Workman
Anti-Cancer Drug Design|August 1, 1994
Signalling targets for the development of cancer drugsG Powis, P Workman
International Journal of Radiation Oncology, Biology, Physics|August 1, 1986
Interaction of nitroimidazole sensitizers with drug metabolizing enzymes--spectral and kinetic studiesF Y Lee, P Workman
Expert Opinion on Pharmacotherapy|October 5, 2001
Innovative cancer drug targets: genomics, transcriptomics and clinomicsP Workman, P A Clarke
International Journal of Cancer|January 2, 1994
Unusually marked hypoxic sensitization to indoloquinone EO9 and mitomycin C in a human colon-tumour cell line that lacks DT-diaphorase activityJ A Plumb, P Workman
Biochemical Pharmacology|January 15, 1978
Enzyme activated anti-tumor agents--IV. Comparative kinetics of N,N-p-di-2-chloroethylaminophenyl phosphate hydrolysis catalysed by phosphatases of normal and neoplastic tissuesP Workman, J A Double
Cancer Chemotherapy and Pharmacology|January 1, 1994
Is body composition an important variable in the pharmacokinetics of anticancer drugs? A review and suggestions for further researchJ J Reilly, P Workman
British Journal of Cancer|May 1, 1993
In vitro antitumour activity of the novel imidazoisoquinoline SDZ 62-434V G Brunton, P Workman
Pageof 27